Clinical Trial

Long-term Follow-up Study of BHC001 for TDT

Recruiting
View on ClinicalTrials.gov →
Summary
Observe long-term safety risk and long-term efficacy after intravenous infusion of BHC001 in TDT subjects.
Trial Details
NCT Number NCT06314529
Lead Sponsor Bioray Laboratories
Collaborators: The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army, Xiangya Hospital of Central South University
Conditions Thalassemia, Beta
Enrollment 6 participants
Start Date 2022-12-14
Primary Completion 2036-12-10 (estimated)
Study Completion 2037-05-10 (estimated)
Updated on ClinicalTrials.gov 2024-03-18